[Application of the variant allele frequency of myeloid-associated gene mutations in myelodysplastic syndrome]. [PDF]
Zhonghua Xue Ye Xue Za ZhiShang MY, Su L.
europepmc +1 more source
[Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma]. [PDF]
Zhonghua Xue Ye Xue Za ZhiSun CY +30 more
europepmc +1 more source
[The role and molecular mechanism of transcription factor EB and its target genes in multiple myeloma treatment with bortezomib]. [PDF]
Zhonghua Xue Ye Xue Za ZhiZhang RJ +8 more
europepmc +1 more source
[Expression of GPRC5D in newly diagnosed patients with multiple myeloma detected by flow cytometry and its prognostic value]. [PDF]
Zhonghua Xue Ye Xue Za ZhiJin CQ, Yan F, Ma A, Xu KL, Xia JY.
europepmc +1 more source
[Clinical characteristics and survival outcomes of patients with immunoglobulin A multiple myeloma in the bortezomib era: A single-center retrospective cohort study]. [PDF]
Zhonghua Xue Ye Xue Za ZhiGao F +5 more
europepmc +1 more source
[Chinese guidelines on response assessment and minimal residual disease monitoring in multiple myeloma (2024)]. [PDF]
Zhonghua Xue Ye Xue Za ZhiMultiple Myeloma Expert Committee of Chinese Society of Clinical Oncology (CSCO) +2 more
europepmc +1 more source
Construction of a treatment response prediction model for multiple myeloma based on multi-omics and machine learning. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanZhou X, Gui R, Liu J, Gao M.
europepmc +1 more source